{"id":49029,"date":"2018-09-22T01:00:00","date_gmt":"2018-09-26T01:54:21","guid":{"rendered":"http:\/\/www.05921.net\/index.php\/2018\/09\/26\/%e5%85%a8%e7%90%8325%e5%a4%a7%e8%8d%af%e4%bc%81%e6%8e%92%e5%90%8d%e6%96%b0%e9%b2%9c%e5%87%ba%e7%82%89%ef%bc%8c%e5%ae%83%e4%bb%ac%e7%9a%84%e8%bf%99%e4%ba%9b%e8%bf%9b%e5%b1%95%e4%bd%a0%e9%83%bd%e7%9f%a5\/"},"modified":"2018-09-26T09:54:22","modified_gmt":"2018-09-26T01:54:22","slug":"%e5%85%a8%e7%90%8325%e5%a4%a7%e8%8d%af%e4%bc%81%e6%8e%92%e5%90%8d%e6%96%b0%e9%b2%9c%e5%87%ba%e7%82%89%ef%bc%8c%e5%ae%83%e4%bb%ac%e7%9a%84%e8%bf%99%e4%ba%9b%e8%bf%9b%e5%b1%95%e4%bd%a0%e9%83%bd%e7%9f%a5","status":"publish","type":"post","link":"https:\/\/www.05921.net\/index.php\/49029\/","title":{"rendered":"\u5168\u740325\u5927\u836f\u4f01\u6392\u540d\u65b0\u9c9c\u51fa\u7089\uff0c\u5b83\u4eec\u7684\u8fd9\u4e9b\u8fdb\u5c55\u4f60\u90fd\u77e5\u9053\u5417\uff1f"},"content":{"rendered":"
\n

\u258e\u836f\u660e<\/span><\/strong>\u5eb7\u5fb7\/\u62a5\u9053<\/span><\/strong><\/strong><\/strong><\/strong><\/span><\/strong><\/strong><\/p>\n


<\/span><\/strong><\/strong><\/strong><\/strong><\/span><\/strong><\/strong><\/p>\n

\u65e5\u524d\uff0c\u5168\u7403\u77e5\u540d\u7684\u6570\u636e\u7edf\u8ba1\u4e0e\u5206\u6790\u673a\u6784GlobalData\u4f9d\u71672018\u5e74\u4e0a\u534a\u5e74\u7684\u5e02\u503c\uff0c\u516c\u5e03\u4e86\u5168\u740325\u5927\u836f\u4f01\u540d\u5355\uff0c\u5f3a\u751f\u3001\u8f89\u745e\u3001\u4ee5\u53ca\u7f57\u6c0f\u4f4d\u5217\u524d\u4e09\uff0c\u6c5f\u82cf\u6052\u745e\u533b\u836f\u4e5f\u6210\u4e3a\u552f\u4e00\u4e00\u5bb6\u8dfb\u8eab\u8be5\u699c\u5355\u7684\u4e2d\u56fd\u533b\u836f\u4f01\u4e1a\u3002<\/strong><\/span><\/p>\n


<\/p>\n

\"\u5168\u740325\u5927\u836f\u4f01\u6392\u540d\u65b0\u9c9c\u51fa\u7089\uff0c\u5b83\u4eec\u7684\u8fd9\u4e9b\u8fdb\u5c55\u4f60\u90fd\u77e5\u9053\u5417\uff1f\"<\/p>\n


<\/p>\n

\u6b63\u5982GlobalData\u6240\u6307\u51fa\u7684\u90a3\u6837\uff0c\u8fd9\u4e9b\u5927\u578b\u533b\u836f\u4f01\u4e1a\u57282018\u5e74\uff0c\u90fd\u6709\u7740\u4e0d\u5c11\u52a8\u6001\uff0c\u4e5f\u53d6\u5f97\u4e86\u559c\u4eba\u7684\u6210\u7ee9\u3002\u6628\u5929\uff0c\u6211\u4eec\u76d8\u70b9\u4e86<\/span>\u524d\u5341\u5bb6\u836f\u4f01\u5728\u4eca\u5e74\u53d6\u5f97\u7684\u8fdb\u5c55<\/span><\/a>\u3002\u4eca\u65e5\uff0c\u6211\u4eec\u5c06\u7ee7\u7eed<\/strong>\u4e3a\u5404\u4f4d\u8bfb\u8005\u670b\u53cb\u4eec\u6574\u7406\u5269\u4e0b15\u5bb6\u836f\u4f01\u7684\u52a8\u6001\u3002<\/strong><\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u845b\u5170\u7d20\u53f2\u514b\uff08GSK\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/span><\/p>\n

\u845b\u5170\u7d20\u53f2\u514b\u5728\u4f20\u67d3\u6027\u75be\u75c5\u4e0a\u53d6\u5f97\u4e86\u8bf8\u591a\u8fdb\u5c55\u3002<\/span><\/strong>\u4eca\u5e742\u6708\uff0c\u5176<\/span>\u4e59\u578b\u8111\u819c\u708e\u75ab\u82d7Bexsero\u83b7\u5f97\u4e86\u7f8e\u56fdFDA\u6388\u4e88\u7684\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff0c\u57282-10\u5c81\u7684\u513f\u7ae5\u4e2d\u9884\u9632\u4e59\u578b\u8111\u819c\u708e\u3002\u8fd9\u4e5f\u662f\u4e16\u754c\u4e0a\u552f\u4e00\u4e00\u4e2a\u4e24\u5ea6\u83b7\u5f97FDA\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\u7684\u75ab\u82d7\u3002\u6b64\u5916\uff0cGSK\u65d7\u4e0b\u7684ViiV Healthcare\u516c\u53f8\u7814\u5236\u7684\u591a\u66ff\u62c9\u97e6\u94a0\uff08dolutegravir\uff0cDTG\uff09\/\u62c9\u7c73\u592b\u5b9a\uff08lamivudine, 3TC\uff09\u53cc\u836f\u6cbb\u7597\u65b9\u6848<\/span>\u8fbe\u52303\u671f\u4e34\u5e8a\u4e3b\u8981\u7ec8\u70b9<\/span><\/a>\uff0c\u6709\u671b\u6cbb\u7597HIV\u611f\u67d3\u60a3\u8005\u3002<\/span><\/p>\n


<\/span><\/p>\n

\u5728\u836f\u7269\u7814\u53d1\u7b56\u7565\u65b9\u9762\uff0cGSK\u79ef\u6781\u62e5\u62b1\u65b0\u5174\u6280\u672f\uff0c\u505a\u51fa\u4e86\u65b0\u7684\u5c1d\u8bd5\u3002\u65e9\u4e9b\u65f6\u5019\uff0cGSK\u4e0e23andMe\u516c\u53f8\u7b7e\u8ba2\u4e86<\/span>\u56db\u5e74\u7684\u5408\u4f5c\u534f\u8bae<\/span><\/a>\uff0c\u5c06\u5229\u752823andMe\u7684\u5927\u89c4\u6a21\u57fa\u56e0\u7ec4\u5b66\u6570\u636e\uff0c\u5e2e\u52a9\u53d1\u73b0\u66f4\u5b89\u5168\u6709\u6548\u7684\u7cbe\u51c6\u836f\u7269\uff0c\u4e3a\u9776\u5411\u7597\u6cd5\u53d1\u73b0\u6700\u5408\u9002\u7684\u60a3\u8005\u7fa4\uff0c\u534f\u52a9\u4e34\u5e8a\u8bd5\u9a8c\u52df\u96c6\u60a3\u8005<\/strong>\u3002\u800c\u4e0eKymera Therapeutics\u7684\u5408\u4f5c\u534f\u8bae\u5219\u53cd\u6620\u4e86GSK\u5bf9\u9776\u5411\u86cb\u767d\u964d\u89e3\u901a\u8def\u8fd9\u4e00\u521b\u65b0\u6cbb\u7597\u65b9\u5f0f\u7684\u5174\u8da3\u3002<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u8d5b\u8bfa\u83f2\uff08Sanofi\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u8d5b\u8bfa\u83f2\u4eca\u5e74\u7684\u52a8\u6001\u4e3b\u8981\u96c6\u4e2d\u4e8e\u4e24\u5757\uff0c\u7b2c\u4e00\u5757\u4e0e\u764c\u75c7\u76f8\u5173\uff1a<\/span><\/strong>\u5176\u5728\u7814PD-1\u6291\u5236\u5242cemiplimab\u83b7\u5f97\u4e86FDA\u6388\u4e88\u7684<\/span>\u4f18\u5148\u5ba1\u8bc4\u8d44\u683c<\/span><\/a>\uff0c\u6709\u671b\u5728\u4eca\u5e7410\u6708\u5e95\u83b7\u6279\u3002\u5982\u679c\u83b7\u6279\uff0c\u5b83\u4e5f\u5c06\u6210\u4e3a\u7b2c\u4e09\u6b3e\u83b7\u6279\u7684PD-1\u6291\u5236\u5242<\/strong>\u3002\u8d5b\u8bfa\u83f2\u540c\u65f6\u4e5f\u901a\u8fc7\u7814\u53d1\u5408\u4f5c\u6269\u5145\u81ea\u8eab\u7684\u7ba1\u7ebf\uff0c\u4eceRevolution Medicines\u83b7\u5f97\u7684SHP2\u6291\u5236\u5242RMC-4630\u5c31\u662f\u8fd9\u6837\u7684\u4f8b\u5b50\uff0c\u5b83\u6709\u671b\u6cbb\u7597\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3002<\/span><\/span><\/span><\/span><\/p>\n


<\/span><\/p>\n

\u8d5b\u8bfa\u83f2\u7684\u53e6\u4e00\u5927\u52a8\u6001\u4e13\u6ce8\u4e8e\u7f55\u89c1\u8840\u6db2\u75be\u75c5<\/span><\/strong>\u3002\u5e74\u521d\uff0c\u8fd9\u5bb6\u516c\u53f8\u5206\u522b\u4ee5116\u4ebf\u7f8e\u5143\u548c39\u4ebf\u6b27\u5143\uff0c\u6536\u8d2d\u4e86\u4e13\u6ce8\u4e8e\u8840\u53cb\u75c5\u7684<\/span>Bioverativ\u516c\u53f8<\/span><\/a>\u4e0e\u4e13\u6ce8\u4e8e\u7eb3\u7c73\u6297\u4f53\u7814\u53d1\u7684<\/span>Ablynx\u516c\u53f8<\/span><\/a>\u3002\u503c\u5f97\u4e00\u63d0\u7684\u662f\uff0c\u540e\u8005\u7684\u65b0\u836fCablivi<\/span>\u5df2\u5728\u672c\u6708\u4e8e\u6b27\u6d32\u83b7\u6279<\/span><\/a>\u3002<\/span><\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u793c\u6765\uff08Eli Lilly\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u793c\u6765\u516c\u53f8\u5728\u4eca\u5e74\u53d6\u5f97\u4e86\u4e0d\u5c11\u79ef\u6781\u76843\u671f\u4e34\u5e8a\u6570\u636e\uff0c\u5176\u6297\u764c\u836f\u7269<\/strong><\/span>Cyramza<\/span><\/a>\u5728\u6cbb\u7597\u809d\u7ec6\u80de\u764c\uff08HCC\uff09\u7684\u4e34\u5e8a3\u671f\u8bd5\u9a8c\u4e2d\u8fbe\u5230\u4e3b\u8981\u7ec8\u70b9\uff0c\u5176\u9488\u5bf9CGRP\u7684\u6297\u4f53<\/span><\/span>galcanezumab<\/span><\/a>\u4e5f\u57283\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8868\u73b0\u51fa\u8272\uff0c\u6709\u671b\u6cbb\u7597\u96c6\u675f\u6027\u5934\u75db\u3002<\/span><\/strong><\/span><\/p>\n


<\/span><\/p>\n

\u5728\u5e76\u8d2d\u4e0e\u5408\u4f5c\u65b9\u9762\uff0c\u793c\u6765\u4eca\u5e74\u6709\u7740\u4e0d\u5c0f\u7684\u52a8\u4f5c\u3002<\/span><\/strong>\u5b83\u5148\u662f\u65a5\u8d4416\u4ebf\u7f8e\u5143\u6536\u8d2d<\/span>Armo Biosciences\u516c\u53f8<\/span><\/a>\uff0c\u53c8\u4e0e<\/span>AurKa Pharma<\/span><\/a>\u7b7e\u8ba2\u4e86\u8fd16\u4ebf\u7f8e\u5143\u7684\u6536\u8d2d\u534f\u8bae\u3002\u8fd9\u4e24\u5bb6\u516c\u53f8\u7684\u5728\u7814\u7597\u6cd5\u80fd\u4ece\u591a\u4e2a\u89d2\u5ea6\u62d3\u5c55\u793c\u6765\u7684\u80bf\u7624\u5b66\u7814\u53d1\u7ba1\u7ebf\u3002<\/strong><\/span><\/p>\n


<\/span><\/p>\n

\u793c\u6765<\/span>\u4e0eSigilon Therapeutics\u7684\u5408\u4f5c\u534f\u8bae<\/span><\/a>\u5219\u53cd\u6620\u4e86\u5176\u5bf9\u65b0\u5174\u7cd6\u5c3f\u75c5\u7597\u6cd5\u7684\u91cd\u89c6<\/strong>\u3002\u8fd9\u5bb6\u516c\u53f8\u6b63\u5728\u5c1d\u8bd5\u7528\u591a\u80fd\u5e72\u7ec6\u80de\u5206\u5316\u5f62\u6210\u80f0\u5c9b\u03b2\u7ec6\u80de\uff0c\u7528\u4e8e\u6cbb\u7597\u7cd6\u5c3f\u75c5\u3002<\/span><\/span><\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u5409\u5229\u5fb7\u79d1\u5b66\uff08Gilead Sciences\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/span><\/p>\n

\u5409\u5229\u5fb7\u79d1\u5b66\u4eca\u5e74\u5728\u6cbb\u7597HIV-1\u611f\u67d3\u9886\u57df\u53d6\u5f97\u4e86\u8bf8\u591a\u53ef\u559c\u7684\u8fdb\u5c55\u3002<\/span><\/strong>\u5176\u65b0\u836f<\/span>Biktarvy<\/span><\/a>\u5728\u4eca\u5e742\u6708\u5f97\u5230\u4e86\u7f8e\u56fdFDA\u7684\u6279\u51c6\u4e0a\u5e02\uff0c<\/span>\u6377\u6276\u5eb7\uff08Genvoya\uff09<\/span><\/a>\u4e5f\u5728\u4eca\u5e745\u6708\u4e8e\u4e2d\u56fd\u83b7\u6279\u3002\u800c\u5728HIV-1\u611f\u67d3\u7684\u6cbb\u7597\u5916\uff0c\u5176\u4e0eGalapagos\u516c\u53f8\u5408\u4f5c\u7814\u53d1\u7684JAK1\u6291\u5236\u5242<\/span><\/span><\/span>filgotinib<\/span><\/a>\u4e5f\u5728\u6cbb\u7597\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u7684\u4e34\u5e8a3\u671f\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u79ef\u6781\u7ed3\u679c\u3002<\/span><\/p>\n

\"\u5168\u740325\u5927\u836f\u4f01\u6392\u540d\u65b0\u9c9c\u51fa\u7089\uff0c\u5b83\u4eec\u7684\u8fd9\u4e9b\u8fdb\u5c55\u4f60\u90fd\u77e5\u9053\u5417\uff1f\"<\/p>\n

\u800c\u4ece\u5409\u5229\u5fb7\u79d1\u5b66\u4e0e\u5176\u4ed6\u516c\u53f8\u7684\u5408\u4f5c\u6765\u770b\uff0c\u6211\u4eec\u53ef\u4ee5\u770b\u5230\u5b83\u4e3a\u672a\u6765\u6301\u7eed\u53d1\u5c55\u6240\u505a\u7684\u5e03\u5c40\u3002\u9996\u5148\uff0c\u5b83\u5c06\u7ee7\u7eed\u6df1\u8015\u4f20\u67d3\u75c5\u9886\u57df\u3002\u6700\u8fd1\uff0c\u5b83\u4e0e<\/span>Precision BioSciences<\/span><\/a>\u516c\u53f8\u8fbe\u6210\u7684\u5408\u4f5c\u5c06\u7528\u57fa\u56e0\u7597\u6cd5\u6e05\u9664\u4e59\u809d\u75c5\u6bd2\u611f\u67d3<\/strong>\uff1b\u800c\u4e4b\u524d\u4e0e<\/span>Hookipa Biotech<\/span><\/a>\u516c\u53f8\u8fbe\u6210\u7684\u5408\u4f5c\uff0c\u5219\u5c06\u7528\u514d\u75ab\u7597\u6cd5\u6cbb\u7597\u4e59\u809d\u548cHIV\u611f\u67d3<\/strong>\u3002<\/span><\/p>\n


<\/span><\/p>\n

\u53e6\u5916\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u5409\u5229\u5fb7\u79d1\u5b66\u4eca\u5e74\u8fd8\u4e0eVerily\u5c55\u5f00\u5408\u4f5c<\/span><\/strong>\uff0c\u5229\u7528\u540e\u8005\u7684Immunoscape\u5e73\u53f0\u53bb\u7406\u89e3\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u3001\u708e\u75c7\u6027\u80a0\u75c5\u3001\u4ee5\u53ca\u72fc\u75ae\u76f8\u5173\u75be\u75c5\u8fd9\u51e0\u79cd\u5e38\u89c1\u708e\u75c7\u6027\u75be\u75c5\u80cc\u540e\u7684\u514d\u75ab\u5b66\u673a\u7406\u3002<\/span><\/span><\/span><\/span><\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\uff08BMS\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n

<\/span>
<\/p>\n

\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u516c\u53f8\u4eca\u5e74\u7684\u4e3b\u8981\u52a8\u6001\u6765\u81ea\u764c\u75c7\u6cbb\u7597\u9886\u57df<\/strong>\uff0c\u5176\u91cd\u78c5\u514d\u75ab\u7597\u6cd5<\/span>Opdivo\uff08\u5546\u54c1\u540d\u6b27\u72c4\u6c83\uff09<\/span><\/a>\u5df2\u6765\u5230\u4e2d\u56fd\u5927\u9646\u5730\u533a\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u8eab\u8fb9\uff0c\u5f00\u542f\u4e86\u4e00\u4e2a\u514d\u75ab\u7597\u6cd5\u65f6\u4ee3\u3002\u5728\u6d77\u5916\uff0cOpdivo\u4e0eYervoy\u7ec4\u6210\u7684\u8054\u5408\u7597\u6cd5\u6709\u671b\u4e00\u7ebf\u6cbb\u7597\u975e\u5c0f\u7ec6\u80de\u80ba\u764c<\/strong>\uff0c\u8fd9\u6b3e\u7ec4\u5408\u7597\u6cd5\u7684\u4e0a\u5e02\u7533\u8bf7\u5df2\u7ecf\u83b7\u5f97\u4e86\u7f8e\u56fdFDA\u7684\u63a5\u53d7\uff0c\u6709\u671b\u660e\u5e74\u7b2c\u4e00\u5b63\u5ea6\u83b7\u6279\u3002<\/span>
<\/p>\n


<\/span><\/p>\n

\u4e0eYervoy\u7684\u7ec4\u5408\u4e4b\u5916\uff0c\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u4e5f\u5728\u79ef\u6781\u63a2\u7d22Opdivo\u7684\u5176\u4ed6\u7ec4\u5408\u53ef\u80fd\u3002\u4eca\u5e74\u521d\uff0c\u8fd9\u5bb6\u516c\u53f8\u5c31\u4e0e<\/span>Nektar Therapeutic<\/span><\/a>\u5c55\u5f00\u5408\u4f5c\uff0c\u5c06\u5176\u5728\u7814\u65b0\u836fNKTR-214\u7eb3\u5165\u7ec4\u5408\u7597\u6cd5\u7684\u8003\u91cf\u8303\u7574\u3002<\/span><\/strong><\/span><\/p>\n


<\/p>\n

\u9664\u6b64\u4e4b\u5916\uff0c\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u5728\u764c\u75c7\u9886\u57df\u4e5f\u53d6\u5f97\u4e86\u4e00\u4e9b\u65b0\u7684\u4e34\u5e8a\u8fdb\u5c55\u2014\u2014Sprycel\u4e0e\u5316\u7597\u6784\u6210\u7684\u8054\u5408\u7597\u6cd5\u6709\u671b\u5728\u4eca\u5e74\u83b7\u6279\uff0c\u6cbb\u7597\u8d39\u57ce\u67d3\u8272\u4f53\u9633\u6027\u7684\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5<\/span><\/strong>\u3002\u800cEmpliciti\u3001pomalidomide\u3001\u4ee5\u53ca\u4f4e\u5242\u91cf\u5730\u585e\u7c73\u677e\u6784\u6210\u7684\u4e09\u8054\u7597\u6cd5\u4e5f\u5df2\u83b7\u5f97\u4e86FDA\u7684\u4f18\u5148\u5ba1\u8bc4\u8d44\u683c\uff0c\u540c\u6837\u6709\u671b\u4eca\u5e74\u83b7\u6279\uff0c\u6cbb\u7597\u591a\u53d1\u6027\u9aa8\u9ad3\u7624<\/strong>\u3002<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n

<\/span>
<\/p>\n

\u963f\u65af\u5229\u5eb7\u4eca\u5e74\u5df2\u6709\u4e24\u6b3e\u65b0\u836f\u83b7\u6279<\/span><\/strong>\uff0c\u5206\u522b\u662f\u6cbb\u7597\u9ad8\u94be\u8840\u75c7\u7684<\/span>Lokelma<\/span><\/a>\u548c\u6cbb\u7597\u6bdb\u7ec6\u80de\u767d\u8840\u75c5\u7684<\/span>Lumoxiti<\/span><\/a>\u3002\u8be5\u516c\u53f8\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5Imfinzi\u4e5f\u83b7\u5f97FDA\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3002\u6b64\u5916\uff0c\u8be5\u516c\u53f8\u6cbb\u7597\u91cd\u5ea6\u54ee\u5598\u7684<\/span>Fasenra<\/span><\/a>\u8868\u73b0\u51fa\u79ef\u6781\u7684\u957f\u671f\u5b89\u5168\u6027\u548c\u7597\u6548\u3002<\/span>
<\/p>\n


<\/p>\n

\u5728\u836f\u7269\u7814\u53d1\u65b9\u9762\uff0c\u963f\u65af\u5229\u5eb7\u6d89\u730e\u5e7f\u6cdb\uff0c\u6d89\u53ca\u5230\u7684\u9886\u57df\u5305\u62ec\u57fa\u56e0\u7597\u6cd5\u6cbb\u7597\u6162\u6027\u80ba\u75c5<\/strong>\uff08<\/span>\u4e0e4D Molecular Therapeutics\u5408\u4f5c<\/span><\/a>\uff09\u3001\u5668\u5b98\u82af\u7247<\/strong>\uff08<\/span>\u4e0eEmulate\u5408\u4f5c<\/span><\/a>\uff09\u3001NASH\u521b\u65b0\u7597\u6cd5<\/strong>\uff08<\/span>\u4e0eIonis Pharmaceuticals\u5408\u4f5c<\/span><\/a>\uff09\u3001\u4ee5\u53ca\u53cc\u7279\u5f02\u6027\u548c\u591a\u7279\u5f02\u6027\u514d\u75ab\u80bf\u7624\u6297\u4f53<\/span><\/strong>\uff08\u4e0eCompugen\u5408\u4f5c<\/span>\uff09\u3002<\/span><\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

CSL<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u5728\u7f8e\u56fd\uff0cCSL Behring\u516c\u53f8\u6cbb\u7597\u6162\u6027\u708e\u75c7\u6027\u8131\u9ad3\u9798\u6027\u591a\u53d1\u6027\u795e\u7ecf\u75c5\uff08CIDP\uff09\u7684<\/span>Hizentra<\/span><\/a>\u83b7\u5f97\u4e86FDA\u6279\u51c6\uff0c\u8fd9\u4e5f\u662f\u9488\u5bf9\u8fd9\u4e00\u75be\u75c5\uff0c\u9996\u6b3e\u83b7\u6279\u7684\u76ae\u4e0b\u7ed9\u836f\u514d\u75ab\u7403\u86cb\u767d\u7597\u6cd5\u3002<\/strong> <\/span><\/p>\n


<\/span><\/p>\n

\u4e3a\u4e86\u62d3\u5c55\u5176\u7ba1\u7ebf\uff0cCSL Behring\u5728\u4eca\u5e748\u6708\u53c8\u6536\u8d2d\u4e86Calimmune\uff0c\u5e76\u83b7\u5f97\u4e86\u5176\u57fa\u56e0\u4e0e\u5e72\u7ec6\u80de\u7597\u6cd5\u5e73\u53f0\u3002<\/strong>\u8fd9\u5c06\u8fdb\u4e00\u6b65\u589e\u5f3a\u5176\u5728\u8840\u6db2\u75c5\u75be\u75c5\u7814\u53d1\u4e0a\u7684\u5b9e\u529b\u3002<\/span><\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u767e\u5065\uff08Biogen\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u767e\u5065\u516c\u53f8\u4eca\u5e74\u7684\u4e00\u98792\u671f\u4e34\u5e8a<\/span>\u8bd5\u9a8c<\/span>\u5f15\u8d77\u4e86\u4e1a\u754c\u7684\u5e7f\u6cdb\u5173\u6ce8<\/span><\/a>\u2014\u2014\u5176\u4e0e\u536b\u6750\u8054\u5408\u5f00\u53d1\u7684\u963f\u5179\u6d77\u9ed8\u75c5\uff08AD\uff09\u7597\u6cd5BAN2401\u4e0d\u4f46\u51cf\u5c11\u4e86\u6dc0\u7c89\u6837\u86cb\u767d\u6c89\u79ef\uff0c\u800c\u4e14\u663e\u8457\u5ef6\u7f13\u4e86AD\u7684\u8fdb\u5c55\u8bc4\u5206\u3002<\/strong>\u5728\u65e0\u6570\u4e34\u5e8a\u8bd5\u9a8c\u5931\u8d25\u4e4b\u540e\uff0c\u8fd9\u4e00\u6210\u529f\u65e0\u7591\u7ed9\u963f\u5179\u6d77\u9ed8\u75c5\u7684\u6cbb\u7597\u9886\u57df\u5e26\u6765\u4e86\u65b0\u7684\u5e0c\u671b\u3002\u6b64\u5916\uff0c\u767e\u5065\u7ee7\u7eed\u6269\u5c55\u4e86\u4e0eIonis Pharmaceuticals\u7684\u5408\u4f5c\uff0c\u7814\u53d1\u9776\u5411RNA\u7684\u521b\u65b0\u7597\u6cd5\u3002<\/span>
<\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u65b0\u57fa\uff08Celgene\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u65b0\u57fa\u516c\u53f8\u4eca\u5e74\u5b8c\u6210\u4e86\u591a\u9879\u6536\u8d2d\u548c\u5408\u4f5c\u534f\u8bae\uff0c\u5927\u5e45\u62d3\u5c55\u4e86\u8be5\u516c\u53f8\u7684\u836f\u7269\u7814\u53d1\u7ba1\u7ebf\u3002<\/span><\/strong>\u5176\u4e2d\u6700\u91cd\u78c5\u65b0\u95fb\u4e4b\u4e00\uff0c\u8fd8\u8981\u6570<\/span>90\u4ebf\u7f8e\u5143\u5bf9Juno Therapeutics\u7684\u6536\u8d2d<\/span><\/a>\u3002\u8fd9\u7b14\u6536\u8d2d\u4e5f\u8ba9\u65b0\u57fa\u6210\u4e3a\u4e86\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u9886\u57df\u7684\u91cd\u8981\u4e00\u5458\u3002\u9664\u6b64\u4e4b\u5916\uff0c\u65b0\u57fa\u8fd8\u62df\u6536\u8d2d\u4f4d\u4e8e\u5723\u5730\u4e9a\u54e5\u7684<\/span>Impact Biomedicines<\/span><\/a>\uff0c\u91d1\u989d\u6700\u9ad8\u53ef\u8fbe70\u4ebf\u7f8e\u5143\u3002<\/span><\/p>\n


<\/span><\/p>\n

\"\u5168\u740325\u5927\u836f\u4f01\u6392\u540d\u65b0\u9c9c\u51fa\u7089\uff0c\u5b83\u4eec\u7684\u8fd9\u4e9b\u8fdb\u5c55\u4f60\u90fd\u77e5\u9053\u5417\uff1f\"<\/span><\/p>\n

\u72ec\u5bb6\u4e13\u8bbfCelgene\u7814\u53d1\u638c\u95e8\u4eba\uff1a\u8fd9\u662f\u6211\u4eec\u521b\u9020\u4e0b\u4e00\u4ee3\u7597\u6cd5\u7684\u79d8\u8bc0<\/a><\/span><\/strong><\/span><\/p>\n


<\/span><\/p>\n

\u65b0\u57fa\u5728\u4eca\u5e74\u7684\u65b0\u5408\u4f5c\u4e5f\u662f\u4e0d\u65ad\u3002\u8fd9\u4e9b\u5408\u4f5c\u6d89\u53ca\u7684\u65b0\u5174\u9886\u57df\u5305\u62ec\u7ec6\u80de\u7597\u6cd5\uff08<\/span>\u4e0ebluebird bio\u548cAbide Therapeutics\u5408\u4f5c<\/span><\/a>\uff09\u3001\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\uff08<\/span>\u4e0eProthena\u5408\u4f5c<\/span><\/a>\uff09\u3001\u53cc\u7279\u5f02\u6027\u6297\u4f53\uff08<\/span>\u4e0eZymeworks\u5408\u4f5c<\/span><\/a>\uff09\uff0c\u4ee5\u53ca\u9488\u5bf9RNA\u526a\u63a5\u51fa\u9519\u7684\u5c0f\u5206\u5b50\u836f\u7269\uff08\u4e0eSkyhawk Therapeutics\u5408\u4f5c\uff09\u3002<\/span><\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u827e\u5c14\u5efa\uff08Allergan\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u5728\u65b0\u836f\u83b7\u6279\u65b9\u9762\uff0c\u827e\u5c14\u5065\u7684\u6297\u751f\u7d20Avycaz\u83b7\u5f97\u7f8e\u56fdFDA\u7684\u6279\u51c6\u6269\u5927\u9002\u5e94\u75c7<\/strong>\uff0c\u6cbb\u7597\u7531\u9769\u5170\u6c0f\u9634\u6027\u83cc\u5bfc\u81f4\u7684\u533b\u9662\u83b7\u5f97\u6027\u7ec6\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u673a\u76f8\u5173\u7ec6\u83cc\u6027\u80ba\u708e\u3002\u800c\u5728\u65b0\u836f\u7814\u53d1\u65b9\u9762\uff0c\u8be5\u516c\u53f8\u7684\u591a\u98793\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u79ef\u6781\u6210\u679c\uff0c\u8fd9\u5305\u62ec\u6cbb\u7597\u504f\u5934\u75db<\/strong>\u7684\u4e24\u79cdCGRP\u53d7\u4f53\u62ee\u6297\u5242ubrogepant\u548catogepant\u3001\u6cbb\u7597\u5e74\u9f84\u76f8\u5173\u9ec4\u6591\u53d8\u6027<\/strong>\u7684abicipar\u3001\u4ee5\u53ca\u6cbb\u7597\u53cc\u76f8\u6291\u90c1\u75c7<\/strong>\uff08bipolar I depression\uff09\u7684cariprazine\u3002<\/span><\/span><\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u590f\u5c14\uff08Shire\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u4eca\u5e748\u6708\uff0c\u590f\u5c14\u7684\u4e00\u6b3e\u65b0\u836f<\/span>Takhzyro<\/span><\/a>\u83b7\u5f97FDA\u6279\u51c6\u4e0a\u5e02\uff0c\u6cbb\u7597\u9057\u4f20\u6027\u8840\u7ba1\u6c34\u80bf\u3002\u800c\u5728\u4eca\u5e745\u6708\uff0c<\/span>\u6b66\u7530\u62df\u4ee5622\u4ebf\u7f8e\u5143\u6536\u8d2d\u590f\u5c14<\/span><\/a>\u7684\u65b0\u95fb\u4e5f\u5f15\u8d77\u4e86\u4e1a\u5185\u7684\u5e7f\u6cdb\u5173\u6ce8\u3002<\/span><\/p>\n


<\/span><\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

Vertex Pharmaceuticals<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

Vertex\u516c\u53f8\u7684\u7814\u53d1\u91cd\u70b9\u4e4b\u4e00\u662f\u56ca\u6027\u7ea4\u7ef4\u5316\u3002\u5728\u8fd9\u4e00\u9886\u57df\uff0cVertex\u4e8e<\/span>\u4eca\u5e74\u53d6\u5f97\u4e86\u4e00\u7cfb\u5217\u597d\u7684\u8fdb\u5c55\u2014\u2014\u5176\u65b0\u836f<\/span>Symdeko<\/span><\/a>\u83b7\u5f97FDA\u6279\u51c6\uff0c\u65b0\u4e00\u4ee3\u5728\u7814\u5019\u9009\u836f\u7269VX-659<\/strong>\u548c<\/strong>VX-455<\/strong>\u4e5f\u5df2\u8fdb\u51653\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/span>\u5728\u5176\u5b83\u9886\u57df\uff0c\u8be5\u516c\u53f8\u7814\u53d1\u7684\u521b\u65b0\u94a0\u79bb\u5b50\u901a\u9053NaV1.8\u6291\u5236\u5242<\/strong>VX-150\u5728<\/span>\u4e34\u5e8a2\u671f\u8bd5\u9a8c<\/a>\u4e2d\u83b7\u5f97\u79ef\u6781\u7ed3\u679c\u3002<\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u5fb7\u56fd\u9ed8\u514b\uff08Merck KGaA\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/span><\/p>\n

\u5fb7\u56fd\u9ed8\u514b\u4e0e\u8f89\u745e\u8054\u5408\u7814\u53d1\u7684PD-L1\u6291\u5236\u5242Bavencio<\/strong>\u4e8e\u53bb\u5e74\u83b7\u6279\u4e0a\u5e02\uff0c\u7528\u4e8e\u6cbb\u7597\u6885\u514b\u5c14\u7ec6\u80de\u764c\u548c\u5c3f\u8def\u4e0a\u76ae\u764c\u3002\u4eca\u5e74\uff0c\u8fd9\u6b3e\u65b0\u836f\u4e5f\u53d6\u5f97\u4e86\u4e0d\u5c11\u65b0\u7684\u8fdb\u5c55\u3002\u5176\u4e0e\u5316\u7597\u7ec4\u6210\u7684\u8054\u5408\u7597\u6cd5\u5728\u6cbb\u7597\u665a\u671f\u80be\u7ec6\u80de\u764c\u76843\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u663e\u8457\u63d0\u9ad8\u4e86\u60a3\u8005\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u3002\u4e0e\u6b64\u540c\u65f6\uff0c\u5fb7\u56fd\u9ed8\u514b\u4e5f<\/span><\/span>\u4e0eVyriad\u5c55\u5f00\u5408\u4f5c<\/span><\/a>\uff0c\u63a2\u7d22Bavencio\u4e0e\u6eb6\u7624\u75c5\u6bd2\u7ec4\u6210\u7684\u8054\u5408\u7597\u6cd5<\/span><\/strong>\u5728\u5b9e\u4f53\u7624\u6cbb\u7597\u4e0a\u7684\u6f5c\u529b\u3002<\/span><\/span><\/p>\n


<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u6c5f\u82cf\u6052\u745e\u533b\u836f\uff08Jiangsu Hengrui Medicine\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\u6c5f\u82cf\u6052\u745e\u533b\u836f\u4eca\u5e74\u6709\u591a\u6b3e\u65b0\u836f\u5728\u4e2d\u56fd\u6279\u51c6\u4e0a\u5e02\uff0c\u5176\u4e2d\u5305\u62ec\u6cbb\u7597\u4e73\u817a\u764c\u7684\u827e\u745e\u59ae\uff08<\/span>\u9a6c\u6765\u9178\u5421\u54af\u66ff\u5c3c\u7247<\/span><\/a>\uff09\u548c\u6cbb\u7597\u5316\u7597\u5e76\u53d1\u75c7\u7684\u827e\u591a\uff08\u786b\u57f9\u975e\u683c\u53f8\u4ead\u6ce8\u5c04\u6db2\uff09\u3002\u8be5\u516c\u53f8\u7814\u53d1\u7684\u6ce8\u5c04\u7528\u5361\u745e\u5229\u73e0\u5355\u6297<\/strong>\uff08\u4eba\u6e90\u5316\u6297PD-1\u5355\u514b\u9686\u6297\u4f53\uff09\u548c\u6ce8\u5c04\u7528\u7532\u82ef\u78fa\u9178\u745e\u9a6c\u5511\u4ed1\u83b7\u5f97\u4e86\u4f18\u5148\u5ba1\u8bc4\u8d44\u683c\uff0c\u6709\u671b\u65e9\u65e5\u6765\u5230\u4e2d\u56fd\u60a3\u8005\u8eab\u8fb9\u3002<\/span><\/p>\n


<\/span><\/p>\n

\u591a\u6b3e\u6052\u745e\u7814\u53d1\u7684\u521b\u65b0\u836f\u4e5f\u987a\u5229\u8d70\u51fa\u56fd\u95e8<\/span><\/strong>\u2014\u2014Arcutis\u516c\u53f8\u83b7\u5f97\u4e86<\/span>\u5176JAK1\u6291\u5236\u5242<\/span><\/strong>SHR0302\u7684\u7814\u53d1\u6388\u6743\uff0c\u800cTG Therapeutics\u516c\u53f8\u5219\u83b7\u5f97\u4e86\u5176BTK\u6291\u5236\u5242<\/span><\/strong>SHR1459\u548cSHR1266\u7684\u7814\u53d1\u8bb8\u53ef\u3002<\/span><\/span><\/span><\/span><\/p>\n


<\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u518d\u751f\u5143\uff08Regeneron\uff09<\/span><\/strong><\/span><\/strong><\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/span><\/p>\n

\u518d\u751f\u5143\u516c\u53f8\u7684Eylea\uff08aflibercept\uff09\u5728\u4eca\u5e74\u53d6\u5f97\u4e86\u4e0d\u5c11\u597d\u6d88\u606f\u3002\u5b83\u7684\u6269\u5927\u9002\u5e94\u75c7\u7533\u8bf7\u83b7\u5f97\u4e86FDA\u7684\u6279\u51c6\uff0c\u7528\u4e8e<\/span>\u6cbb\u7597\u6e7f\u6027AMD<\/span><\/a>\u3002\u5176\u7528\u4e8e<\/span>\u6cbb\u7597\u7cd6\u5c3f\u75c5\u89c6\u7f51\u819c\u75c5\u53d8<\/span><\/a>\u7684\u7533\u8bf7\u4e5f\u5f97\u5230\u4e86FDA\u7684\u63a5\u53d7\u3002\u9664\u6b64\u4e4b\u5916\uff0c\u8be5\u516c\u53f8\u7684\u9aa8\u6027\u5173\u8282\u708e\u65b0\u836f\u548c\u7279\u5e94\u6027\u76ae\u708e\u65b0\u836f\u5728\u4e34\u5e8a3\u671f\u8bd5\u9a8c\u4e2d\u5747\u6709\u51fa\u8272\u7684\u8868\u73b0\u3002<\/span>
<\/p>\n


<\/span><\/p>\n

\u518d\u751f\u5143\u516c\u53f8\u4e5f\u6ce8\u91cd\u62d3\u5c55\u65b0\u7684\u9886\u57df\u3002\u4eca\u5e74\uff0c\u5b83\u5206\u522b\u4e0ebluebird bio\u548cAlnylam\u8fdb\u884c\u5408\u4f5c\uff0c\u5c06<\/span>\u764c\u75c7\u514d\u75ab\u7597\u6cd5<\/span><\/a>\u548c<\/span>\u6cbb\u7597NASH\u7684RNAi\u7597\u6cd5<\/span><\/a>\u5f15\u5165\u4e86\u8be5\u516c\u53f8\u7684\u7814\u53d1\u7ba1\u7ebf\u3002<\/span><\/p>\n


<\/p>\n

\u6211\u4eec\u76f8\u4fe1\u5165\u9009\u5168\u740325\u5927\u836f\u4f01\u699c\u5355\u662f\u4e00\u4efd\u8ba4\u53ef\uff0c\u66f4\u662f\u4e00\u4efd\u8d23\u4efb<\/strong>\u3002\u6211\u4eec\u671f\u5f85\u8bf8\u591a\u533b\u836f\u4f01\u4e1a\u80fd\u4e0d\u65ad\u63a8\u52a8\u521b\u65b0\uff0c\u79ef\u6781\u8fdb\u53d6\uff0c\u4e3a\u5168\u7403\u60a3\u8005\u5e26\u6765\u66f4\u591a\u597d\u836f\u65b0\u836f\uff01<\/span><\/p>\n


<\/span><\/p>\n

\u76f8\u5173\u9605\u8bfb\uff1a<\/span><\/strong>\u5168\u740325\u5927\u836f\u4f01\u6392\u540d\u65b0\u9c9c\u51fa\u7089\uff0c\u6c5f\u82cf\u6052\u745e\u533b\u836f\u699c\u4e0a\u6709\u540d<\/span><\/a><\/p>\n


<\/span><\/p>\n

\u672c\u6587\u9898\u56fe\u6765\u81ea123RF\u3002<\/span><\/span><\/p>\n


<\/span><\/p>\n

\u672c\u6587\u6765\u81ea\u836f\u660e\u5eb7\u5fb7\u5fae\u4fe1\u56e2\u961f\uff0c\u6b22\u8fce\u8f6c\u53d1\u5230\u670b\u53cb\u5708\uff0c\u8c22\u7edd\u8f6c\u8f7d\u5230\u5176\u4ed6\u5e73\u53f0\uff1b\u5982\u6709\u5f00\u8bbe\u767d\u540d\u5355\u9700\u6c42\uff0c\u8bf7\u5728\u6587\u7ae0\u5e95\u90e8\u7559\u8a00\uff1b\u5982\u6709\u5176\u4ed6\u5408\u4f5c\u9700\u6c42\uff0c\u8bf7\u8054\u7cfbwuxi_media@wuxiapptec.com<\/span>
<\/p>\n


<\/span><\/p>\n

\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

\u258e\u836f\u660e\u5eb7\u5fb7\/\u62a5\u9053 \u65e5\u524d\uff0c\u5168\u7403\u77e5\u540d\u7684\u6570\u636e\u7edf\u8ba1\u4e0e\u5206\u6790\u673a\u6784GlobalData\u4f9d\u71672018\u5e74\u4e0a\u534a\u5e74\u7684\u5e02\u503c\uff0c\u516c\u5e03\u4e86\u5168\u7403 […]<\/p>\n","protected":false},"author":1,"featured_media":49030,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/49029"}],"collection":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/comments?post=49029"}],"version-history":[{"count":1,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/49029\/revisions"}],"predecessor-version":[{"id":49034,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/49029\/revisions\/49034"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media\/49030"}],"wp:attachment":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media?parent=49029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/categories?post=49029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/tags?post=49029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}